Madison, WI USA. (March 30, 2020)
Promega Corporation is part of a new public-private partnership among Wisconsin industry leaders to increase the state’s laboratory testing capacity for COVID-19. Wisconsin Governor Tony Evers made the announcement today.
The expanded capacity from this new partnership is expected to initially double testing capacity in Wisconsin, currently averaging 1,500-2,000 COVID-19 tests per day, and continue to expand as additional platforms and supplies become available.
“Promega is providing the reagents needed for COVID-19 tests as part of a collective initiative to accelerate testing in Wisconsin. Labs in the state that are running these tests have expressed great confidence in Promega’s ability to manufacture the vital reagents required for the necessary analysis. As needed, Promega scientists and engineers will help fine-tune methods on robots and instrumentation, allowing for high-throughput testing. Promega began scaling up reagent manufacturing in January to address global needs, and has maintained accelerated production since then. Operations teams continue to work on ways to expand production to further meet unprecedented demand,” said Promega CEO, Bill Linton. “Everyone at Promega feels a deep commitment to humanity’s battle against COVID-19, especially given our highly specialized capacity to contribute to this fight. We are honored to join in this historic collaboration between local businesses, labs and state agencies working together to significantly scale up testing capabilities for the people of Wisconsin.”
Read Gov. Evers’ full press release here.
About Promega Corporation
Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company’s 4,000 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, drug discovery and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 16 countries and over 50 global distributors. For more information about Promega, visit www.promega.com.